ArticleJugan geon-gang gwa jilbyeong2024
[Addition of Three Viruses to the High-risk Pathogens of the Infectious Disease Prevention and Management Act].
Article in Jugan geon-gang gwa jilbyeong, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
According to the Infectious Disease Control and Prevention Act, the Korea Centers for Disease Control and Prevention Agency (KDCA) had designated 36 pathogens as high-risk pathogens (HRPs) because of their potential to pose a serious threat to public health and their possible use in bioterrorism. The KDCA is responsible for the national biosafety management of these pathogens. In July 2023, Chapare virus and Lujo virus, both hemorrhagic fever viruses classified under Risk Group 4, along with poliovirus, which is targeted for eradication according to the World Health Organization Global Action Plan Ⅲ, were added to the list of HRPs. This revision has increased the total number of HRPs under national biosafety management to 39. The KDCA will continue to monitor and update the HRPs that require biosafety management in response to the changing environment, which includes emerging and re-emerging pathogens, as well as those requiring international cooperation for biosafety management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.